2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

NCT00075608 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped poor accrual

Conditions

Multiple Myeloma
Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
DRUG: melphalan
PROCEDURE: autologous stem cell transplantation
PROCEDURE: stem cell infusion

Sponsor

Boston Medical Center